These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 31890741)
1. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media. Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741 [TBL] [Abstract][Full Text] [Related]
2. Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production. Bauler M; Ferrara F; Lowe B; Beard JA; Wincek C; Wielgosz MM; Park JJ; Shang N; Nandy S; Li C; Langfitt DM; Zhou S; Throm RE Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101270. PubMed ID: 38883976 [TBL] [Abstract][Full Text] [Related]
3. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture. Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417 [TBL] [Abstract][Full Text] [Related]
4. Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA. Lu XA; He T; Han Z; Ding Y; Zhao L; Liu G; De Smet F; Huang X; Chen D; Qi F; Zhao X Cytotechnology; 2020 Oct; 72(6):897-905. PubMed ID: 33123933 [TBL] [Abstract][Full Text] [Related]
5. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles. Mitta B; Rimann M; Fussenegger M Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993 [TBL] [Abstract][Full Text] [Related]
6. Generation of stable suspension producer cell lines for serum-free lentivirus production. Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592 [TBL] [Abstract][Full Text] [Related]
7. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. Grieger JC; Soltys SM; Samulski RJ Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810 [TBL] [Abstract][Full Text] [Related]
8. Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene. Ali S; Rivera M; Ward J; Keshavarz-Moore E; Mason C; Nesbeth DN Heliyon; 2023 Jun; 9(6):e17067. PubMed ID: 37484388 [TBL] [Abstract][Full Text] [Related]
9. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection. Kuroda H; Kutner RH; Bazan NG; Reiser J J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057 [TBL] [Abstract][Full Text] [Related]
10. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells. Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755 [TBL] [Abstract][Full Text] [Related]
12. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors. Bell AJ; Fegen D; Ward M; Bank A Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083 [TBL] [Abstract][Full Text] [Related]
13. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423 [TBL] [Abstract][Full Text] [Related]
14. Large-scale production means for the manufacturing of lentiviral vectors. Schweizer M; Merten OW Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245 [TBL] [Abstract][Full Text] [Related]
15. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy. Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682 [TBL] [Abstract][Full Text] [Related]
17. Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor. Powers AD; Drury JE; Hoehamer CF; Lockey TD; Meagher MM Mol Ther Methods Clin Dev; 2020 Dec; 19():1-13. PubMed ID: 32995355 [TBL] [Abstract][Full Text] [Related]
18. Characterization of lentiviral vector production using microwell suspension cultures of HEK293T-derived producer cells. Guy HM; McCloskey L; Lye GJ; Mitrophanous KA; Mukhopadhyay TK Hum Gene Ther Methods; 2013 Apr; 24(2):125-39. PubMed ID: 23461548 [TBL] [Abstract][Full Text] [Related]
19. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures. Vaz TA; Rodrigues AF; Coroadinha AS Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159 [TBL] [Abstract][Full Text] [Related]
20. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Hildinger M; Baldi L; Stettler M; Wurm FM Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]